FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2141803 · Received June 27, 2011

Report

Report Number
2024168-2011-04512
Event Type
Injury
Date Received
June 27, 2011
Date of Event
June 1, 2011
Report Date
June 3, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THE STENT REMAINS IN THE PATIENT. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL ADDITIONAL RELEVANT INFORMATION.

Additional Manufacturer Narrative · 1

(B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. HYPERSENSITIVITY/ALLERGIC REACTION IS A KNOWN ADVERSE EVENT AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING. FOLLOW UP INFORMATION RECEIVED CONFIRMED THAT IN AN EXPERT MEDICAL OPINION, IT WAS CONCLUDED THAT THE ETIOLOGY OF THE ALLERGIC REACTION AND KIDNEY FAILURE WAS ANTI-THROMBOTIC MEDICATION, NOT THE XIENCE V STENT. THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT DEVELOPED AN ALLERGIC REACTION AFTER IMPLANTATION OF A XIENCE STENT ON AN UNSPECIFIED DATE. THOUGH REQUESTED, ADDITIONAL INFORMATION WAS NOT PROVIDED.

Description of Event or Problem · 1

SUBSEQUENT TO THE INITIAL MEDWATCH REPORT, EXPERT MEDICAL OPINION CONCLUDED THAT THE ETIOLOGY OF THE ALLERGIC REACTION WAS ANTI-THROMBOTIC MEDICATION, NOT THE XIENCE V STENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT

Patients

Seq Age Sex Outcome Treatment
1 Other